Literature DB >> 6788293

Effect of sulphonylurea on insulin secretion and glucose control in insulin-treated diabetics.

E A Ward, G M Ward, R C Turner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6788293      PMCID: PMC1506311          DOI: 10.1136/bmj.283.6286.278

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  5 in total

1.  A simple and rational twice daily insulin regime. Distinction between basal and meal insulin requirements.

Authors:  M Phillips; R W Simpson; R R Holman; R C Turner
Journal:  Q J Med       Date:  1979-07

2.  Determination of free and total insulin and C-peptide in insulin-treated diabetics.

Authors:  H Kuzuya; P M Blix; D L Horwitz; D F Steiner; A H Rubenstein
Journal:  Diabetes       Date:  1977-01       Impact factor: 9.461

3.  C-peptide in juvenile diabetics beyond the postinitial remission period. Relation to clinical manifestations at onset of diabetes, remission and diabetic control.

Authors:  J Ludvigsson; L G Heding; Y Larsson; E Leander
Journal:  Acta Paediatr Scand       Date:  1977-03

4.  C-peptide secretion and insulin antibodies as determinants of stability in diabetes mellitus.

Authors:  D K Yue; R C Baxter; J R Turtle
Journal:  Metabolism       Date:  1978-01       Impact factor: 8.694

5.  Direct in vitro effect of a sulfonylurea to increase human fibroblast insulin receptors.

Authors:  M J Prince; J M Olefsky
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

  5 in total
  3 in total

1.  Sulphonylurea and insulin: combined treatment in type 1 (insulin-dependent) diabetes.

Authors:  B J Burke
Journal:  Diabetologia       Date:  1985-03       Impact factor: 10.122

Review 2.  The insulin receptor concept and its relation to the treatment of diabetes.

Authors:  G M Ward
Journal:  Drugs       Date:  1987-02       Impact factor: 9.546

3.  Tolbutamide does not alter insulin requirement in Type 1 (insulin-dependent) diabetes.

Authors:  K P Ratzmann; B Schulz; P Heinke; W Besch
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.